Raphael Wisniewski Insider Profile
4 Followers
Raphael Wisniewski, former Director at Tobira Therapeutics, holds 2.96M shares in Axonics Modulation Technologies (Ticker: ~AXNX), holds 2.41M shares in Tobira Therapeutics (Ticker: TBRA). Most recently, Raphael Wisniewski Sold ― shares of Axonics Modulation Technologies on Jan 22, 2020 for an estimated value of $9.46M.
Raphael Wisniewski's Trading History
| ~AXNXAxonics Modulation Technologies | Jan 22, 2020 | ― | Informative Sell | 9.46M | $209.92M | |
| TBRATobira Therapeutics | Aug 29, 2013 | ― | Uninformative Buy | ― | $101.32M |
You May Also Like
Raphael Wisniewski insider profile FAQ
What is the percentage of profitable transactions made by Raphael Wisniewski?
The percentage of profitable transactions made by Raphael Wisniewski is 33%.
What is the average return per transaction made by Raphael Wisniewski?
The average return per transaction made by Raphael Wisniewski is -41.90%.
What stocks does Raphael Wisniewski hold?
Raphael Wisniewski holds: TBRA, ~AXNX stocks.
What was Raphael Wisniewski’s latest transaction?
Raphael Wisniewski’s latest transaction was an Informative Sell of $9.46M.
What was Raphael Wisniewski's most profitable transaction?
Raphael Wisniewski’s most profitable transaction was an Informative Buy of ~AXNX stock on November 2, 2018. The return on the trade was 66.50%.
What is Raphael Wisniewski's role in Tobira Therapeutics?
Raphael Wisniewski's role in Tobira Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
